...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Hello? Anyone over here?

Hi SanFran

I used to post on IV years ago and went over there to read a post by Fundamentals 6 which was reflecting on some od DM's comments at an AGM.

Thinking about what they should know now at this stage of the prostate cancer trial....I am very excited.

Share
New Message
Please login to post a reply